3 results
Approved WMOCompleted
The primary objective of this study is to determine whether the Impella cVAD device vs. IABP therapy leads to a higher 30 day survival rate in shock STEMI patients in the setting of primary PCI.
Approved WMOPending
Primary:Is the degree of pupildilation, achieved after administrating a 4.5 microliter microdrop tropicamide 0.5% equivalent to the pupildilation after a regular 30 microliter eydrop tropicamide 0.5% in healthy volunteers?Secondary: Is there a…
Approved WMOCompleted
To evaluate the safety and performance of the Neovasc Tiara MitralTranscatheter Heart Valve with the Tiara Transapical Delivery System.Data collected in this clinical study will include 30-day safety and performance ofthe device and delivery system…